{"id":8210,"date":"2019-07-09T12:02:25","date_gmt":"2019-07-09T09:02:25","guid":{"rendered":"https:\/\/www.nove.ee\/?p=8210"},"modified":"2021-12-30T17:20:52","modified_gmt":"2021-12-30T15:20:52","slug":"nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou","status":"publish","type":"post","link":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/","title":{"rendered":"NOVE advised sale of 100%  Mercurio O\u00dc shareholding to OneMed"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.nove.ee\/en\/\">NOVE<\/a> partner Urmas Volens and lawyer <a href=\"https:\/\/www.nove.ee\/en\/team\/triin-tiru\/\">Triin Tiru<\/a> advised seller in a transaction, resulting in <a href=\"ttps:\/\/www.onemed.com\/\">OneMed O\u00dc<\/a>, one of the leading medical products distributors in Northern Europe, acquiring 100% ownership of <a href=\"http:\/\/www.mercurio.ee\/\">Mercurio O\u00dc<\/a>.<\/p>\n\n\n\n<p>Mercurio operates in the Baltics mainly as a distributor of <a href=\"https:\/\/www.resmed.com\/epn\/en\/index.html\" target=\"_blank\" rel=\"noreferrer noopener\">ResMed<\/a> sleep apnea equipment and accessories since 2011 and has become the market\nleader in the industry due to its great effort and smart operating. Mercurio\nmanages networked innovative medical data systems and medical devices web store\n<a href=\"https:\/\/meditsiiniseadmed.ee\/\">Meditsiiniseadmed.ee<\/a>. In addition\nto distributing ResMed equipment and accessories, Mercurio is also Baltic\npartner to <a href=\"https:\/\/noxmedical.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Nox Medical<\/a>, the world&#8217;s leading developer and manufacturer of respiratory\ndiagnosis devices, and <a href=\"https:\/\/www.nonin.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Nonin<\/a>, the world&#8217;s leading developer and\nmanufacturer of pulse oximetry equipment. <\/p>\n\n\n\n<p>According to OneMed, who acquired the sole ownership in Mercurio,\n\u201cOneMed O\u00dc is honored to lead such exemplary company to its further development\nphase. From the point of view of OneMed&#8217;s expansion and development, this step\nis of strategic importance, and the promotion of similar views and values in\nthe field of medical supplies is also very important. The activities of\nMercurio O\u00dc so far continue in the same spirit, with the desire to ensure\nsmooth communication and convenient service for all patients and partners.\u201d<\/p>\n\n\n\n<p>NOVE&#8217;s advice included drafting transaction documents as well as\nsupporting the client in conducting a legal audit, negotiating, and dealing\nwith any legal issues that arose in connection with the transaction. In the\nareas of activity of NOVE, the transaction covered <a href=\"https:\/\/www.nove.ee\/en\/mergers-and-acquisitions-ma-and-corporate-law\/\">M&amp;A<\/a>,\n<a href=\"https:\/\/www.nove.ee\/en\/general-contract-law\/\">General Contract Law<\/a>,\n<a href=\"https:\/\/www.nove.ee\/en\/data-protection\/\">Data Protection<\/a> and <a href=\"https:\/\/www.nove.ee\/en\/medical-law\/\">Medical Law<\/a>. Founded in 2016,\nNOVE is a fast-growing new-generation law firm that, in addition to its\nspecialization in litigation, has expanded its business to include M&amp;A,\nreal estate, company law, data protection, medical law and competition law.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NOVE partner Urmas Volens and lawyer Triin Tiru advised seller in a transaction, resulting in OneMed O\u00dc, one of the leading medical products distributors in Northern Europe, acquiring 100% ownership of Mercurio O\u00dc. Mercurio operates&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[85],"tags":[],"class_list":["post-8210","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed - Nove Advokaadib\u00fcroo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed - Nove Advokaadib\u00fcroo\" \/>\n<meta property=\"og:description\" content=\"NOVE partner Urmas Volens and lawyer Triin Tiru advised seller in a transaction, resulting in OneMed O\u00dc, one of the leading medical products distributors in Northern Europe, acquiring 100% ownership of Mercurio O\u00dc. Mercurio operates...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/\" \/>\n<meta property=\"og:site_name\" content=\"Nove Advokaadib\u00fcroo\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-09T09:02:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-30T15:20:52+00:00\" \/>\n<meta name=\"author\" content=\"NOVE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"NOVE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/\"},\"author\":{\"name\":\"NOVE\",\"@id\":\"https:\/\/www.nove.ee\/#\/schema\/person\/d581cf623f3b9cd7deb827c460e362bb\"},\"headline\":\"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed\",\"datePublished\":\"2019-07-09T09:02:25+00:00\",\"dateModified\":\"2021-12-30T15:20:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/\"},\"wordCount\":305,\"publisher\":{\"@id\":\"https:\/\/www.nove.ee\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/\",\"url\":\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/\",\"name\":\"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed - Nove Advokaadib\u00fcroo\",\"isPartOf\":{\"@id\":\"https:\/\/www.nove.ee\/#website\"},\"datePublished\":\"2019-07-09T09:02:25+00:00\",\"dateModified\":\"2021-12-30T15:20:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.nove.ee\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.nove.ee\/#website\",\"url\":\"https:\/\/www.nove.ee\/\",\"name\":\"Nove Advokaadib\u00fcroo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.nove.ee\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.nove.ee\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.nove.ee\/#organization\",\"name\":\"Nove Advokaadib\u00fcroo\",\"url\":\"https:\/\/www.nove.ee\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.nove.ee\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.nove.ee\/wp-content\/uploads\/2025\/10\/nove-eng.svg\",\"contentUrl\":\"https:\/\/www.nove.ee\/wp-content\/uploads\/2025\/10\/nove-eng.svg\",\"width\":374,\"height\":154,\"caption\":\"Nove Advokaadib\u00fcroo\"},\"image\":{\"@id\":\"https:\/\/www.nove.ee\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.nove.ee\/#\/schema\/person\/d581cf623f3b9cd7deb827c460e362bb\",\"name\":\"NOVE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9da97741ea033a410896dbbb534d50609893c91de27c4a7b4e256b3d13d3e6b8?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9da97741ea033a410896dbbb534d50609893c91de27c4a7b4e256b3d13d3e6b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9da97741ea033a410896dbbb534d50609893c91de27c4a7b4e256b3d13d3e6b8?s=96&d=mm&r=g\",\"caption\":\"NOVE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed - Nove Advokaadib\u00fcroo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/","og_locale":"en_US","og_type":"article","og_title":"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed - Nove Advokaadib\u00fcroo","og_description":"NOVE partner Urmas Volens and lawyer Triin Tiru advised seller in a transaction, resulting in OneMed O\u00dc, one of the leading medical products distributors in Northern Europe, acquiring 100% ownership of Mercurio O\u00dc. Mercurio operates...","og_url":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/","og_site_name":"Nove Advokaadib\u00fcroo","article_published_time":"2019-07-09T09:02:25+00:00","article_modified_time":"2021-12-30T15:20:52+00:00","author":"NOVE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"NOVE","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/#article","isPartOf":{"@id":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/"},"author":{"name":"NOVE","@id":"https:\/\/www.nove.ee\/#\/schema\/person\/d581cf623f3b9cd7deb827c460e362bb"},"headline":"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed","datePublished":"2019-07-09T09:02:25+00:00","dateModified":"2021-12-30T15:20:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/"},"wordCount":305,"publisher":{"@id":"https:\/\/www.nove.ee\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/","url":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/","name":"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed - Nove Advokaadib\u00fcroo","isPartOf":{"@id":"https:\/\/www.nove.ee\/#website"},"datePublished":"2019-07-09T09:02:25+00:00","dateModified":"2021-12-30T15:20:52+00:00","breadcrumb":{"@id":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.nove.ee\/en\/nove-advised-transaction-which-resulted-in-onemed-ou-acquiring-100-stake-in-mercurio-ou\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.nove.ee\/en\/"},{"@type":"ListItem","position":2,"name":"NOVE advised sale of 100% Mercurio O\u00dc shareholding to OneMed"}]},{"@type":"WebSite","@id":"https:\/\/www.nove.ee\/#website","url":"https:\/\/www.nove.ee\/","name":"Nove Advokaadib\u00fcroo","description":"","publisher":{"@id":"https:\/\/www.nove.ee\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nove.ee\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.nove.ee\/#organization","name":"Nove Advokaadib\u00fcroo","url":"https:\/\/www.nove.ee\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.nove.ee\/#\/schema\/logo\/image\/","url":"https:\/\/www.nove.ee\/wp-content\/uploads\/2025\/10\/nove-eng.svg","contentUrl":"https:\/\/www.nove.ee\/wp-content\/uploads\/2025\/10\/nove-eng.svg","width":374,"height":154,"caption":"Nove Advokaadib\u00fcroo"},"image":{"@id":"https:\/\/www.nove.ee\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.nove.ee\/#\/schema\/person\/d581cf623f3b9cd7deb827c460e362bb","name":"NOVE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9da97741ea033a410896dbbb534d50609893c91de27c4a7b4e256b3d13d3e6b8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9da97741ea033a410896dbbb534d50609893c91de27c4a7b4e256b3d13d3e6b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9da97741ea033a410896dbbb534d50609893c91de27c4a7b4e256b3d13d3e6b8?s=96&d=mm&r=g","caption":"NOVE"}}]}},"_links":{"self":[{"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/posts\/8210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/comments?post=8210"}],"version-history":[{"count":4,"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/posts\/8210\/revisions"}],"predecessor-version":[{"id":9244,"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/posts\/8210\/revisions\/9244"}],"wp:attachment":[{"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/media?parent=8210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/categories?post=8210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nove.ee\/en\/wp-json\/wp\/v2\/tags?post=8210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}